NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Latest figures show the number dropped to 204,000 in the year to June 2025, down 69% year-on-year from 649,000.Read More
